BioCryst Pharmaceuticals, Inc. (BCRX)
8.79
-0.04
(-0.45%)
USD |
NASDAQ |
May 07, 14:09
BioCryst Pharmaceuticals Profit Margin (Quarterly) : -461.5% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -17.07% |
| KalVista Pharmaceuticals, Inc. | -8.96% |
| Lantheus Holdings, Inc. | 13.30% |
| Revolution Medicines, Inc. | -- |
| Plus Therapeutics, Inc. | -417.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -96.91% |
| Return on Invested Capital | -139.9% |
| Gross Profit Margin (Quarterly) | 96.56% |
| Operating Margin (Quarterly) | -2.45% |
| Return on Net Operating Assets | -379.2% |